10:36 EDT Biohaven (BHVN) down 12% to $20.60 after pulling European application Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More on BHVN: Biohaven trading resumes Biohaven withdraws troriluzole marketing application in Europe Biohaven trading halted, volatility trading pause RBC sees Makary interview as potentially positive for biotech stocks Biohaven call buyer realizes 15% same-day gains Disclaimer & DisclosureReport an Issue
